Rhythm Pharmaceuticals, Inc. ( RYTM) - Key Metrics
RYTM Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $1.04 | -$0.72 | -$0.78 | -$0.78 |
| 2026Q1 | $0.88 | -$0.82 | -$0.65 | -$0.65 |
| 2025Q4 | $0.86 | -$0.71 | -$0.38 | -$0.39 |
| 2025Q3 | $0.80 | -$0.82 | -$0.41 | -$0.41 |
| 2025Q2 | $0.76 | -$0.73 | -$0.37 | -$0.37 |
RYTM Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -38.02 |
| 2026Q1 | 0% | -26.20 |
| 2025Q4 | 0% | -36.66 |
| 2025Q3 | 0% | -30.79 |
| 2025Q2 | 0% | -21.06 |
RYTM
Price: $115.48
52 week price:
Earnings Per Share: -3.12 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 483700
Ebitda: -8.2 millionMarket Capitalization: 7.9 billion